This inventor holds 4 USPTO granted patents and 7 published patent applications. Top assignee: Neuroderm, Ltd.. Active years: 2022-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2023
Title: The Innovations of Itay Perlstein
Introduction
Itay Perlstein is a notable inventor based in Philadelphia, PA, who has made significant contributions to the field of neurology. With a focus on innovative treatments for neurological disorders, he holds 4 patents that reflect his dedication to improving patient outcomes.
Latest Patents
Perlstein's latest patents include groundbreaking methods for the treatment of Parkinson's disease. One of his patents discloses a method for treating this neurological disorder through parenteral administration of levodopa, a levodopa salt, or a levodopa prodrug, combined with a dopa decarboxylase inhibitor (DDCI) such as carbidopa. This method is designed to be administered alongside oral doses of levodopa and DDCI. Another patent outlines a similar approach, emphasizing the importance of both parenteral and oral administration in effectively managing Parkinson's disease.
Career Highlights
Itay Perlstein is currently associated with Neuroderm, Ltd., where he continues to develop innovative solutions for neurological disorders. His work is characterized by a commitment to advancing medical treatments that can significantly enhance the quality of life for individuals suffering from movement disorders.
Collaborations
Perlstein collaborates with talented professionals in his field, including colleagues Tal Birnberg and Liat Adar. Their combined expertise fosters an environment of innovation and progress in the development of new treatment methodologies.
Conclusion
Itay Perlstein's contributions to the field of neurology through his patents and collaborative efforts highlight his role as a key innovator in the treatment of Parkinson's disease. His work continues to pave the way for advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
